# Hui Zhang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hui-zhang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,221 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 65 |
| i10-index | 328 |
| Last Known Institution | Xuzhou Medical College |
| OpenAlex ID | https://openalex.org/A5100323343 |
| ORCID iD | https://orcid.org/0000-0001-6825-5649 |
| Works | 894 |

## Researcher papers

- [Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study](https://scholariq.org/papers/pralsetinib-for-ret-fusion-positive-non-small-cell-lung-cancer-arrow-a-multi/)
- [Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients](https://scholariq.org/papers/functional-impairment-in-circulating-and-intrahepatic-nk-cells-and-relative/)
- [Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial](https://scholariq.org/papers/neural-stem-cell-delivery-of-an-oncolytic-adenovirus-in-newly-diagnosed/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Statistical Methods and Bayesian Inference](https://scholariq.org/topics/statistical-methods-and-bayesian-inference/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Researcher university

- [Xuzhou Medical College](https://scholariq.org/institutions/xuzhou-medical-college/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.